18109-81-4
Chemical Structure
Butamirate citrate
- CAS No.: 18109-81-4
- Formula:C24H37NO10
- Molecular Weight:499.55
IUPAC Name: 2-(2-(diethylamino)ethoxy)ethyl 2-phenylbutanoate 2-hydroxypropane-1,2,3-tricarboxylate
InChIKey: JVKMHUAWFDGPTF-UHFFFAOYSA-N
SMILES: O=C(OCCOCCN(CC)CC)C(CC)C1=CC=CC=C1.O=C(CC(C(O)=O)(O)CC(O)=O)O
Biological Activity: Butamirate citrate is an orally active antitussive agent that acts centrally through the receptors in the brainstem. Butamirate citrate also reduces the resistance in the airways by inhibiting bronchospasm and anti-inflammatory effect. Butamirate citrate inhibits glioblastoma (GBM) growth and STAT3 activity. Butamirate citrate can be used for the study of glioblastoma[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Butamirate citrate | 99.88% | Butamirate citrate is an orally active antitussive agent that acts centrally through the receptors in the brainstem. Butamirate citrate also reduces the resistance in the airways by inhibiting bronchospasm and anti-inflammatory effect. Butamirate citrate inhibits glioblastoma (GBM) growth and STAT3 activity. Butamirate citrate can be used for the study of glioblastoma. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Butamirate citrate (Standard) | ≥98% | Butamirate citrate (Standard) is the analytical standard of Butamirate citrate (HY-118545A). This product is intended for research and analytical applications. Butamirate citrate is an orally active antitussive agent that acts centrally through the receptors in the brainstem. Butamirate citrate also reduces the resistance in the airways by inhibiting bronchospasm and anti-inflammatory effect. Butamirate citrate inhibits glioblastoma (GBM) growth and STAT3 activity. Butamirate citrate can be used for the study of glioblastoma. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Butamirate-d5 citrate | Butamirate-d5 citrate is the deuterium labeled Butamirate citrate. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
- [1]. Płusa T. [Butamirate citrate in control of cough in respiratory tract inflammation]. Pol Merkur Lekarski. 2017 Aug 21;43(254):69-74. Polish. [Content Brief]
- [2]. Lee SJ, et al. Application of the antitussive agents oxelaidin and butamirate as anti-glioma agents. Sci Rep. 2021 May 12;11(1):10145. [Content Brief]
